Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS)

Autor: Lengliné, Etienne, Baba, Joachim, de Boissieu, Paul, Beaufils, Alexandre, Desbiolles, Alice, Diatta, Thierno, Cochat, Pierre, Chevret, Sylvie
Zdroj: In European Journal of Cancer June 2024 204
Databáze: ScienceDirect